학술논문
Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH-LT study
Document Type
Article
Author
Source
In: Alimentary Pharmacology and Therapeutics . (Alimentary Pharmacology and Therapeutics, February 2024, 59(4):526-534)
Subject
Language
English
ISSN
13652036
02692813
02692813